Advances in prodrug design
Mini-Reviews in Medicinal Chemistry, v. 5, n. 10, p. 893-914, 2005.
Távora de Albuquerque Silva, Antonio
Chin, Chung Man
Castro, Lúcia Fioravanti
Carvalho Güido, Rafael Victorio
Ferreira, Elizabeth Igne
The background of prodrug design is presented herein as the basis for introducing new and advanced latent systems, taking into account mainly the versatility of polymers and other macromolecules as carriers. PDEPT (Polymer-Directed Enzyme Prodrug Therapy); PELT (Polymer-Enzyme Liposome Therapy); CDS (Chemical Delivery System); ADEPT(Antibody-Directed Enzyme Prodrug Therapy); GDEPT/VDEPT (Gene-Directed Enzyme Prodrug Therapy/Virus-Directed Enzyme Prodrug Therapy); ODDS (Osteotropic Drug Delivery System) and LEAPT (Lectin-directed enzyme-activated prodrug therapy) are briefly described and some examples are given. © 2005 Bentham Science Publishers Ltd.
Showing items related by title, author, creator and subject.
Potential tuberculostatic agent: Micelle-forming pyrazinamide prodrug Silva, M.; Ricelli, N. L.; El Seoud, O.; Valentim, C. S.; Ferreira, A. G.; Sato, D. N.; Leitel, CQF; Ferreira, E. I.
Potential tuberculostatic agents: Micelle-forming copolymer poly(ethylene glycol)-poly(aspartic acid) prodrug with isoniazid Universidade Estadual Paulista (Unesp); Universidade de São Paulo (USP) (Wiley-Blackwell, 2001-06-01)With the objective of obtaining slow-acting isoniazid derivatives, of potential use as chemoprophylactics or chemotherapeutics in tuberculosis, the micelle-forming copolymer of poly(ethylene glycol)-poly(aspartic acid) ...
Potential tuberculostatic agent: Micelle-forming pyrazinamide prodrug Universidade Estadual Paulista (Unesp); Universidade de São Paulo (USP); Universidade Federal de São Carlos (UFSCar); Instituto Adolfo Lutz (IAL) (Wiley-Blackwell, 2006-06-01)Pyrazinamide was condensed with the poly(ethylene glycol)-poly(aspartic acid) copolymer (PEG-PASP), a micelle-forming derivative was obtained that was characterized in terms of its critical micelle concentration (CMC) and ...